Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines

被引:58
|
作者
Hjorto, Gertrud M. [1 ]
Larsen, Olav [1 ]
Steen, Anne [1 ]
Daugvilaite, Viktorija [1 ]
Berg, Christian [1 ]
Fares, Suzan [1 ]
Hansen, Morten [2 ]
Ali, Simi [3 ]
Rosenkilde, Mette M. [1 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Panum Inst, Dept Neurosci & Pharmacol, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, CCIT, Dept Haematol, Herlev, Denmark
[3] Newcastle Univ, Fac Med, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
来源
FRONTIERS IN IMMUNOLOGY | 2016年 / 7卷
关键词
CCR7; CCL19; CCL21; tailless-CCL21; dendritic cell; biased signaling; ERK; RECEPTOR CCR7; TRANSMEMBRANE HELICES; FUNCTIONAL LIGAND; MIGRATION; EXPRESSION; CCL21; CCL19; IDENTIFICATION; ACTIVATION; BINDING;
D O I
10.3389/fimmu.2016.00568
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CCR7 ligands CCL19 and CCL21 are increasingly recognized as functionally different (biased). Using mature human dendritic cells (DCs), we show that CCL19 is more potent than CCL21 in inducing 3D chemotaxis. Intriguingly, CCL21 induces prolonged and more efficient ERK1/2 activation compared with CCL19 and a C-terminal truncated (tailless) CCL21 in DCs. In contrast, tailless-CCL21 displays increased potency in DC chemotaxis compared with native CCL21. Using a CCL21-specific antibody, we show that CCL21, but not tailless-CCL21, accumulates at the cell surface. In addition, removal of sialic acid from the cell surface by neuraminidase treatment impairs ERK1/2 activation by CCL21, but not by CCL19 or tailless-CCL21. Using standard laboratory cell lines, we observe low potency of both CCL21 and tailless-CCL21 in G protein activation and beta-arrestin recruitment compared with CCL19, indicating that the tail itself does not improve receptor interaction. Chemokines interact with their receptors in a stepwise manner with ultimate docking of their N-terminus into the main binding pocket. Employing site-directed mutagenesis we identify residues in this pocket of selective CCL21 importance. We also identify a molecular switch in the top of TM7 important for keeping CCR7 in an inactive conformation (Tyr312), as introduction of the chemokine receptor-conserved Glu (or Ala) induces high constitutive activity. Summarized, we show that the interaction of the tail of CCL21 with polysialic acid is needed for strong ERK signaling, whereas it impairs CCL21-mediated chemotaxis and has no impact on receptor docking consistent with the current model of chemokine: receptor interaction. This indicates that future selective pharmacological targeting of CCL19 versus CCL21 should focus on a differential targeting of the main receptor pocket, while selective targeting of tailless-CCL21 versus CCL21 and CCL19 requires targeting of the glycosaminoglycan (GAG) interaction.
引用
收藏
页数:15
相关论文
共 29 条
  • [21] Role of the chemokine receptors CXCR3, CXCR4 and CCR7 in the intramuscular recruitment of plasmacytoid dendritic cells in dermatomyositis
    Lv, Jingwei
    Li, Ling
    Li, Wei
    Ji, Kunqian
    Hou, Ying
    Yan, Chuanzhu
    Dai, Tingjun
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 319 : 142 - 148
  • [22] Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
    Roberts, Edward W.
    Broz, Miranda L.
    Binnewies, Mikhail
    Headley, Mark B.
    Nelson, Amanda E.
    Wolf, Denise M.
    Kaisho, Tsuneyasu
    Bogunovic, Dusan
    Bhardwaj, Nina
    Krummel, Matthew F.
    CANCER CELL, 2016, 30 (02) : 324 - 336
  • [23] CCL19 promotes TNF-alpha/IFN-gamma-induced production of cytokines by targeting CCR7/NF-κB signalling in HaCaT cells
    Zeng, Ying
    Nie, Xiaoqi
    Deng, Yunhua
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2024, 62 (04) : 203 - 211
  • [24] Bisoprolol reverses epinephrine-mediated inhibition of cell emigration through increases in the expression of β-arrestin 2 and CCR7 and PI3K phosphorylation, in dendritic cells loaded with cholesterol
    Yang, Hong
    Du, Rong-Zeng
    Qiu, Jian-Ping
    Tang, Yong-Qing
    Chen, Shi-Chao
    THROMBOSIS RESEARCH, 2013, 131 (03) : 230 - 237
  • [25] CCR7 ligands up-regulate IL-23 through PI3-kinase and NF-κB pathway in dendritic cells
    Kuwabara, Taku
    Tanaka, Yuriko
    Ishikawa, Fumio
    Kondo, Motonari
    Sekiya, Hideki
    Kakiuchi, Terutaka
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 92 (02) : 309 - 318
  • [26] Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
    Taraldsrud, E.
    Fevang, B.
    Aukrust, P.
    Beiske, K. H.
    Floisand, Y.
    Froland, S.
    Rollag, H.
    Olweus, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (03) : 439 - 448
  • [27] Bryostatin-1, a Naturally Occurring Antineoplastic Agent, Acts as a Toll-like Receptor 4 (TLR-4) Ligand and Induces Unique Cytokines and Chemokines in Dendritic Cells
    Ariza, Maria Eugenia
    Ramakrishnan, Rupal
    Singh, Narendra P.
    Chauhan, Ashok
    Nagarkatti, Prakash S.
    Nagarkatti, Mitzi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (01) : 24 - 34
  • [28] The phosphoinositide-3-kinase (PI3K)-delta inhibitor seletalisib impairs monocyte-derived dendritic cells maturation, APC function, and promotes their migration to CCR7 and CXCR4 ligands
    Scopelliti, Fernanda
    Mercurio, Laura
    Cattani, Caterina
    Dimartino, Valentina
    Albanesi, Cristina
    Costanzo, Gianfranco
    Mirisola, Concetta
    Madonna, Stefania
    Cavani, Andrea
    JOURNAL OF LEUKOCYTE BIOLOGY, 2022, 112 (03) : 383 - 393
  • [29] NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis
    Nico, Dirlei
    Almeida, Fernanda Martins
    Motta, Juliana Maria
    dos Santos Cardoso, Fellipe Soares
    Freire-de-Lima, Celio Geraldo
    Freire-de-Lima, Leonardo
    de Luca, Paula Melo
    Blanco Martinez, Ana Maria
    Morrot, Alexandre
    Palatnik-de-Sousa, Clarisa Beatriz
    FRONTIERS IN IMMUNOLOGY, 2018, 9